SEVARO is a healthcare technology company that provides teleneurology services for patients with neurological disorders.
SEVARO has raised $39.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.
SEVARO's investors include APA Venture Partners, Intermountain Ventures, Catalyst Investors, Valtruis.
SEVARO is headquartered in New York, United States.
SEVARO is a healthcare technology company that provides teleneurology services for patients with neurological disorders.
SEVARO is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SEVARO — Funding & Investors." VCBacked, September 18, 2025, https://www.vcbacked.co/company/sevaro. Accessed August 1, 2026.
VCBacked. (2025). SEVARO — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/sevaro
{{cite web |title=SEVARO — Funding & Investors |url=https://www.vcbacked.co/company/sevaro |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated